Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Adamis Pharmaceuticl (ADMP)

Adamis Pharmaceuticl (ADMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,799
  • Shares Outstanding, K 61,634
  • Annual Sales, $ 15,090 K
  • Annual Income, $ -39,010 K
  • 60-Month Beta 1.38
  • Price/Sales 3.55
  • Price/Cash Flow N/A
  • Price/Book 1.42
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.74
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.04
  • Number of Estimates 2
  • High Estimate -0.01
  • Low Estimate -0.07
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +85.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.52 +83.46%
on 10/21/19
1.08 -11.67%
on 11/08/19
+0.41 (+76.67%)
since 10/18/19
3-Month
0.48 +98.75%
on 10/16/19
1.11 -14.05%
on 08/21/19
-0.13 (-11.67%)
since 08/19/19
52-Week
0.48 +98.75%
on 10/16/19
3.29 -71.00%
on 02/26/19
-1.55 (-61.84%)
since 11/19/18

Most Recent Stories

More News
Adamis Pharmaceuticals Announces Publication of Comparative Pharmacokinetics of Community Use Naloxone Formulations

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis") announced today that an article entitled "Comparative Pharmacokinetic Analysis of Community Use Naloxone Formulations for Acute Treatment of...

ADMP : 0.95 (+9.64%)
Adamis Pharmaceuticals (ADMP) Reports Q3 Loss, Misses Revenue Estimates

Adamis (ADMP) delivered earnings and revenue surprises of -83.33% and -9.88%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

ADMP : 0.95 (+9.64%)
Adamis: 3Q Earnings Snapshot

SAN DIEGO (AP) _ Adamis Pharmaceuticals Corp. (ADMP) on Tuesday reported a loss of $7 million in its third quarter.

ADMP : 0.95 (+9.64%)
Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the third quarter ended September 30, 2019 and provided a business update.

ADMP : 0.95 (+9.64%)
Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options

Investors need to pay close attention to Adamis Pharmaceuticals (ADMP) stock based on the movements in the options market lately.

ADMP : 0.95 (+9.64%)
Adamis Pharmaceuticals Schedules Third Quarter 2019 Earnings Conference Call and Business Update

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis") announced today that it will host an investor conference call on Tuesday, November 12, 2019 at 2:00 pm Pacific Time to discuss its financial...

ADMP : 0.95 (+9.64%)
Adamis Pharmaceuticals Provides Regulatory Update for Its Higher Dose Naloxone Pre-Filled Syringe

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis") today announced that as of the close of business today, Adamis has not received any notice of action from the U.S. Food and Drug Administration...

ADMP : 0.95 (+9.64%)
Will Adamis Pharmaceuticals (ADMP) Report Negative Q3 Earnings? What You Should Know

Adamis (ADMP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ADMP : 0.95 (+9.64%)
Adamis Pharmaceuticals Announces Presentation of ZIMHI data at IHV Scientific Meeting

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis") announced today the presentation of data pertaining to its investigational high dose naloxone product (ZIMHI) at the Institute of Human Virology...

ADMP : 0.95 (+9.64%)
Adamis Pharmaceuticals Announces Commercial Partnership with Emerge Health for SYMJEPI(R) in Australia and New Zealand

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that it has entered into an exclusive distribution and commercialization agreement with Emerge Health Pty ("Emerge") to register and commercialize...

ADMP : 0.95 (+9.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft.

See More Share

Trade ADMP with:

Business Summary

Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned...

See More

Key Turning Points

2nd Resistance Point 1.02
1st Resistance Point 0.99
Last Price 0.95
1st Support Level 0.89
2nd Support Level 0.83

See More

52-Week High 3.29
Fibonacci 61.8% 2.22
Fibonacci 50% 1.88
Fibonacci 38.2% 1.55
Last Price 0.95
52-Week Low 0.48

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar